A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Current and future use of dipyridamole in patients with COVID-19
2020
KaÄ?estvennaâ kliniÄ?eskaâ praktika
Preserved Fulltext
Current use of dipyridamole in COVID-19 is mainly based on its antithrombotic activity, since there is no robust clinical effectiveness data. The decision to use dipyridamole in COVID-19 should be individualized, considering the experimental nature of this treatment.
doi:10.37489/2588-0519-2020-s4-92-95
fatcat:xl64z7whtjcrhbkswcf7jccjui